Submissions

Online Submissions

Already have a Username/Password for Microbiologia Medica?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

To submit a new paper to our journal:

  1. Register as an Author; we encourage you to register also as a Reader and a Reviewer at the same time;
  2. Follow the Guidelines for Authors;
  3. Read our Editorial Policies and our Competing Interest policies.


To submit a revised version:

  1. Log in;
  2. Click on your role as Author;
  3. Click on IN REVIEW: REVISIONS REQUIRED or RESUBMIT FOR REVIEW on the page displayed (under the heading ‘Status’, near the manuscript title);
  4. Under the heading EDITOR DECISION, upload your revised paper as AUTHOR VERSION using Browse and Upload buttons;
  5. Use the NOTIFY EDITOR e-mail button to inform the Editors that the revised version has been submitted.


Guidelines for Authors

Manuscripts submitted to Microbiologia Medica must represent reports of original research. All results previously presented at a scientific meeting or in another public context must be declared, giving the context, location and date of presentation.

Studies addressed to diagnostic tests must follow the recommendations reported in Standards for Reporting of Diagnostic Accuracy (STARD): http://www.equator-network.org/reporting-guidelines/stard/

After publication the copyright of the article transfers to AMCLI.

As an option, PAGEPress offers its own professional copyediting service.
Professional copyeditingcan help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:

1. Manuscript preparation

Manuscripts should be structured as follows: Title page, Summary, Introduction, Materials and Methods (or Patients and Methods), Results, Discussion, Acknowledgements, References, Figures and Tables. Times New Roman 12 is the advised font; lines should be numbered and 1,5 spaced; pages should be numbered consecutively (including first page).

Manuscripts must be submitted in English (UK spelling). Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission.

Do not duplicate data and information by presenting them both in the text and in figures/tables.

Genus and species names should be written in italic and in full when first cited. The names should be then abbreviated, provided that no ambiguity will arise.

Only generic names of drugs should be used, although trade names may follow in parentheses (only if necessary for comprehension). Brand and company names and locations for equipment, compounds and substances should be included in parentheses within the text.

Authors are kindly required to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process).


2. Full text

First page: the title page must contain: a) a concise but informative title; b) names and surnames of all authors; c) their affiliating institutions indicated by Arabic numbers; d) name and surname, address, tel/fax numbers and e-mail address of the author to whom correspondence should be addressed; e) a short running title; and f) no more than 6 key words.

Second page: it should contain a) authors' contributions, i.e., information about the contributions of each person named as having participated in the study (http://www.icmje.org/#author); b) disclosures about potential conflict of interest.

Summary: it should not exceed 250 words. It must be structured in: background and aims, materials and methods, results and conclusions.

Introduction: the introduction should briefly explain the background of the study and the purpose of the paper.

Materials and methods: this section should describe materials or subjects, as well as methods, used in the paper, sufficiently in detail to allow other researchers to reproduce the study. Each innovative technique must be detailed, while for usual methods a bibliographic citation is required. Any procedure used for quality control must be specified.

Results: results presented in tabular or illustrative form should not be reiterated in the text; only the most salient findings should be emphasized. Any interpretation of data included in the Discussion must be avoided.

Discussion: the relevance of the study’s results in comparison with other data from previous literature should be underlined. It should be stated whether the aim of the study has been achieved or not. Information presented in the Introduction should not be repeated.

Acknowledgements: any grant or funding must be acknowledged; any technical assistance and contributions not justifying authorship must be included as well.

References: they must be listed in alphabetic order. The author is responsible for the accuracy and completeness of all references, which should be listed in alphabetic order and numbered, with the numbers cited in the text in brackets before punctuation marks, according to the Vancouver style (examples following).

  • Articles
    Goate AM, Haynes AR, Owen MJ, et al. Predisposing locus for Alzheimier’s disease on chromosome 21. Lancet 1989; 1: 352-5.
  • Books
    Roberts GD, Koneman EW, Him YK. Mycobacterium. In: Manual of Clinical Microbiology, Balows A, Isenberg HD Eds, Fifth Edition. American Society for Microbiology, Washington DC 1991; 304-39.
  • Chapter from a Book
    Hedburgh H, Nord CE. Anaerobic bacteria. In: Yu VL, Weber R, Raoult D, eds. Antimicrobial therapy and vaccines. 2nd edn. New York: Apple Tree Productions, 2002: 55-63.


Tables: Tables should be numbered consecutively with Arabic numbers, in the order they are first presented in the text. Each Table (not tab.) should be presented in the text. Each table must be given a title, which should be descriptive enough to stand alone. Any abbreviations and symbols should be defined in the Table footnotes. Written permission to reproduce data from another source (published or not) must be obtained before publication.

Figures: Figures may include graphs, good laser prints or photographs. Figures should be numbered consecutively with Arabic numbers, in the order they are first presented in the text. Each Figure (not fig.) should be presented in the text. A different caption for each figure must be provided at the end of the manuscript, on a separate sheet, and not included in the figure. Written permission to reproduce data from another source (published or not) must be obtained before publication.

 

3. Sections

Editorials: they should addressed any topic arisen from recent publications, as a matter of discussion. They are generally invited papers. They must not exceed 3000 words, including references. Summary is not required.

Reviews: Reviews are expected to be focused on topics relevant for clinical microbiology. he manuscript should not exceed 5000 words, including references.

Original articles: Original articles report original observations, new techniques or methods. The manuscript (in total 2500 words) should be structured as follows: summary, introduction, materials and methods, results, discussion, up to 30 references.

Clinical reports: clinical cases should not exceed 1500 words; they refer to clinical situations with particular interest for clinical microbiology. The text should include a summary, a brief introduction, the case description (clinical symptoms, laboratory tests and any useful observation) the results of the study, up to 10 references.

Short communications: they are short papers (no more than 1000 words). The text should include: brief summary (max. 500 words), introduction, type of the study, conclusions, up to 15 references.

Letters to the Editor: they must refer to a paper recently published in MM. The letter will be sent to the original authors to solicit a reply. The original letter and the possible reply will be published simultaneously. The letter must include max 500 words (with a Figure or a Table if required) and up to 5 references.

 


Peer-review policy

All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article’s appropriateness for our journals’ readership; ii) to define the manuscript’s priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).

Authorship: all persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials): the ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research: when reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (as revised in 2008). In particular, PAGEPress adopts the WAME policy on Ethics in Research (http://www.wame.org). Documented review and approval from a formally constituted review board (Institutional Review Board - IRB - or Ethics committee) is required for all studies (prospective or retrospective) involving people, medical records, and human tissues. When reporting experiments on animals, authors will be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in Microsoft Word, or PDF document file format.
  3. We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  5. Authors are kindly required to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process)
  6. Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
 

Copyright Notice

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

1. The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
2. A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms: 1. The copyright holders grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. 3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

 

Privacy Statement

Privacy is an important concern for users of our site, and is something that PAGEPress takes very seriously. Below you will find our policy for protecting users' personal information. Registration on our website is optional and voluntary. Browsing and viewing articles on our website does not require any personal information to be submitted from users. Nor do these functions require the user's browser to be set to accept cookies. Some other aspects of our services published on our website do require the use of cookies, and the supply of information such as name, e-mail etc. This is necessary for security reasons and also for us to be able to assure standards of scientific integrity. Users may submit further personal information (e.g. details of research areas of interest) in order to take advantage of present and future personalization facilities on our website. In accordance with European Union guidelines, registrants may decline to provide the information requested. They should be advised, however, that PAGEPress may be unable to deliver its services unless at least the information necessary for security and identification purposes is provided. In order to offer the best possible service to users, PAGEPress tracks the patterns of usage of pages on the site. This enables us to identify the most popular articles and services. Where users have provided details of their research areas of interest, this information can be correlated, helping PAGEPress to provide a useful service for scientists, offering them the most relevant information based on their areas of interest. User information will only be shared with third parties with the explicit consent of the user. Publishing a scientific manuscript is inherently a public (as opposed to anonymous) process. The name and e-mail address of all authors of a PAGEPress manuscript will be available to users of PAGEPress. These details are made available in this way purely to facilitate scientific communication. Collecting these e-mail addresses for commercial use is not allowed, nor will PAGEPress itself send unsolicited e-mail to authors, unless it directly concerns the paper they have published on PAGEPress journals. PAGEPress reserves the right to disclose members' personal information if required to do so by law, or in the good faith and belief that such action is reasonably necessary to comply with legal process, respond to claims, or protect the rights, property or safety of PAGEPress, employees or members.

 
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185